236 related articles for article (PubMed ID: 33310480)
1. Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.
Fu J; Jia Q; Zhou H; Zhang L; Wang S; Liang P; Lv Y; Han S
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122469. PubMed ID: 33310480
[TBL] [Abstract][Full Text] [Related]
2. Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.
Wang N; Han S; Liu R; Meng L; He H; Zhang Y; Wang C; Lv Y; Wang J; Li X; Ding Y; Fu J; Hou Y; Lu W; Ma W; Zhan Y; Dai B; Zhang J; Pan X; Hu S; Gao J; Jia Q; Zhang L; Ge S; Wang S; Liang P; Hu T; Lu J; Wang X; Zhou H; Ta W; Wang Y; Lu S; He L
Phytomedicine; 2020 Dec; 79():153333. PubMed ID: 32920291
[TBL] [Abstract][Full Text] [Related]
3. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.
Badraoui R; Adnan M; Bardakci F; Alreshidi MM
Molecules; 2021 Jan; 26(3):. PubMed ID: 33525415
[TBL] [Abstract][Full Text] [Related]
5. Investigating interactions between chloroquine/hydroxychloroquine and their single enantiomers and angiotensin-converting enzyme 2 by a cell membrane chromatography method.
Jia Q; Fu J; Liang P; Wang S; Wang Y; Zhang X; Zhou H; Zhang L; Lv Y; Han S
J Sep Sci; 2022 Jan; 45(2):456-467. PubMed ID: 34729910
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine and Hydroxychloroquine Increase Retinal Pigment Epithelial Layer Permeability.
Korthagen NM; Bastiaans J; van Meurs JC; van Bilsen K; van Hagen PM; Dik WA
J Biochem Mol Toxicol; 2015 Jul; 29(7):299-304. PubMed ID: 25752684
[TBL] [Abstract][Full Text] [Related]
7. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
Rodrigo C; Fernando SD; Rajapakse S
Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak.
Nicolò M; Ferro Desideri L; Bassetti M; Traverso CE
Int Ophthalmol; 2021 Feb; 41(2):719-725. PubMed ID: 32946004
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Modulatory Effect of Hydroxychloroquine on ACE2 Activity: New Insights in relation to COVID-19.
Tichauer JE; Soto D; Andresen M
Biomed Res Int; 2021; 2021():6614000. PubMed ID: 34337036
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties.
Warhurst DC; Steele JC; Adagu IS; Craig JC; Cullander C
J Antimicrob Chemother; 2003 Aug; 52(2):188-93. PubMed ID: 12837731
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis.
Lin YC; Lin JF; Wen SI; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
Kaohsiung J Med Sci; 2017 May; 33(5):215-223. PubMed ID: 28433067
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Chloroquine and Hydroxychloroquine on ACE2-Related Coronavirus Pathology and the Cardiovascular System: An Evidence-Based Review.
Chen L; Chen H; Dong S; Huang W; Chen L; Wei Y; Shi L; Li J; Zhu F; Zhu Z; Wang Y; Lv X; Yu X; Li H; Wei W; Zhang K; Zhu L; Qu C; Hong J; Hu C; Dong J; Qi R; Lu D; Wang H; Peng S; Hao G
Function (Oxf); 2020; 1(2):zqaa012. PubMed ID: 38626250
[TBL] [Abstract][Full Text] [Related]
13. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
[TBL] [Abstract][Full Text] [Related]
14. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19.
Naghipour S; Ghodousi M; Rahsepar S; Elyasi S
Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1119-1133. PubMed ID: 32631083
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E
Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535
[TBL] [Abstract][Full Text] [Related]
16. Affinity binding of COVID-19 drug candidates (chloroquine/hydroxychloroquine) and serum albumin: Based on photochemistry and molecular docking.
Hu LY; Yuan Y; Wen ZX; Hu YY; Yin MM; Hu YJ
J Photochem Photobiol B; 2023 Mar; 240():112667. PubMed ID: 36753782
[TBL] [Abstract][Full Text] [Related]
17. Chloroquine- and Hydroxychloroquine-Induced Cardiomyopathy: A Case Report and Brief Literature Review.
Nadeem U; Raafey M; Kim G; Treger J; Pytel P; N Husain A; Schulte JJ
Am J Clin Pathol; 2021 May; 155(6):793-801. PubMed ID: 33316045
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
20. Chiral distinction between hydroxychloroquine enantiomers in binding to angiotensin-converting enzyme 2, the forward receptor of SARS-CoV-2.
Aiello F; Balzano F; Uccello Barretta G; D'Acquarica I; Mazzoccanti G; Agranat I
J Pharm Biomed Anal; 2024 Jan; 237():115770. PubMed ID: 37879140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
